Li Li WANG ; Chuan Ying GENG ; Yan Ru ZHANG ; Yin WU
Chinese Journal of Hematology 2022;43(1):75-77
Antineoplastic Agents/therapeutic use* ; Bortezomib/therapeutic use* ; Humans ; Inappropriate ADH Syndrome/chemically induced* ; Multiple Myeloma/drug therapy*